智能手机患者中心糖尿病照护系统对2型糖尿病患者的疗效:24周随机对照试验
本24周多中心随机对照试验纳入血糖控制不佳的成人2型糖尿病患者,比较智能手机患者中心糖尿病照护系统(mDiabetes)与纸质记录本(pLogbook)的疗效。主要终点为两组HbA1c自基线变化差值,mDiabetes组HbA1c降幅大于pLogbook组,且更多患者达到HbA1c<7.0%且无低血糖,安全性可耐受。
要点
- mDiabetes组HbA1c降幅大于pLogbook组,调整后均值差0.35%(95%CI 0.14-0.55,P=0.001)。
- mDiabetes组41.1%患者HbA1c<7.0%,pLogbook组20.7%(OR 2.01,95%CI 1.24-3.25,P=0.003)。
- 两组严重高血糖和低血糖事件数无差异。
核心结论
- 对血糖控制不佳的2型糖尿病患者,实施mDiabetes可显著降低HbA1c,安全性可耐受。
研究设计与样本
- 24周多中心随机对照试验,纳入血糖控制不佳的成人2型糖尿病患者,随机分为mDiabetes组(n=90)和pLogbook组(n=82)。
主要发现
- mDiabetes组HbA1c自基线降幅为-0.40±0.09%(n=90),pLogbook组为-0.06±0.10%(n=82)。
- 调整后均值变化差值为0.35%(95%CI 0.14-0.55,P=0.001)。
- mDiabetes组41.1%患者HbA1c<7.0%(53 mmol/mol),pLogbook组20.7%(OR 2.01,95%CI 1.24-3.25,P=0.003)。
- mDiabetes组31.1%患者达到HbA1c<7.0%且无低血糖,pLogbook组17.1%(OR 1.82,95%CI 1.03-3.21,P=0.024)。
- 两组严重高血糖和低血糖事件数无差异。
关键数值与推荐
- 主要终点为两组HbA1c自基线变化差值。
- mDiabetes系统包含血糖监测、饮食、体力活动和临床决策支持系统等综合模块。
临床怎么用
- 对于血糖控制不佳的2型糖尿病患者,可考虑使用智能手机患者中心糖尿病照护系统辅助管理以改善血糖控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluated the efficacy of a smartphone-based, patient-centered diabetes care system (mDiabetes) for type 2 diabetes that contains comprehensive modules for glucose monitoring, diet, physical activity, and a clinical decision support system. RESEARCH DESIGN AND METHODS: We conducted a 24-week, multicenter, randomized controlled trial with adult patients with inadequately controlled type 2 diabetes. The patients were randomly assigned to the mDiabetes group or the paper logbook (pLogbook) group. The primary end point was the difference of the change in HbA1c from baseline between the two groups. RESULTS: HbA1c reduction from baseline was greater in the mDiabetes group (-0.40 ± 0.09%, n = 90) than in the pLogbook group (-0.06 ± 0.10%, n = 82). The difference of adjusted mean changes was 0.35% (95% CI 0.14-0.55, P = 0.001). The proportion of patients whose HbA1c fell below 7.0% (53 mmol/mol) was 41.1% for the mDiabetes group and 20.7% for the pLogbook group (odds ratio [OR] 2.01, 95% CI 1.24-3.25, P = 0.003). The percentage of patients who attained HbA1c levels below 7.0% (53 mmol/mol) without hypoglycemia was 31.1% in the mDiabetes group and 17.1% in the pLogbook group (OR 1.82, 95% CI 1.03-3.21, P = 0.024). There was no difference in the event numbers of severe hyperglycemia and hypoglycemia between the two groups. CONCLUSIONS: The implementation of the mDiabetes for patients with inadequately controlled type 2 diabetes resulted in a significant reduction in HbA1c levels, with tolerable safety profiles.
引用
- Kim EK, Kwak SH, Jung HS, et al. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes Care. 2018. PMID: 30377185. doi:10.2337/dc17-2197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。